Compromised Wound Healing Flashcards
bone remodeling allows what?
for our bones to repair from daily micro-trauma
what are some common reasons of compromised wound healing?
- medications
- radiotherapy (XRT)
- infection
- systemic disease
disease associated with bone healing problems
- drug (medication) related osteonecrosis (MRONJ) of the jaws
- osteo-radio-necrosis (ORN)
- osteomyelitis
drugs associated with MRONJ
- bisphosphonates
- anti-resorptive agents
- anti-angiogenic medications
example of anti-resorptive agents
- denosumab (Prolia, Xgeva)
example of anti-angiogenic medications
- tyrosine kinase inhibitors
- monoclonal antibodies targeting VEGF
- Sunitinib
what are bisphosphonates (BP)?
synthetic analogs of inorganic pyrophosphate
how does bisphosphonates (BP) work?
- high affinity for Ca2+
- inhibition of osteoclasts
- may inhibit capillary neo-angiogenesis
indications for ORAL bisphosphonates (BP)
- osteoporosis
- osteopenia
- Paget’s disease
- osteogenesis imperfecta
indicatiosn for IV bisphosphonates (BP)
- bone metastases associated with solid tumors
- hypercalcemia of malignancy
- multiple myeloma
diagnosis of MRONJ
- current or previous tx with bisphosphonates (BP)
- exposed bone in the maxillofacial region that has persisted for more than EIGHT weeks
- no history of radiation therapy to the jaws
commonly prescribed ORAL bisphosphonates (BP)
- Fosamax (alendronate)
2. Actonel (risedronate)
commonly prescribed IV bisphosphonates (BP)
- Aredia (pamidronate)
- Zometa (zolendronate)
- Reclast (zolendronate)
commonly prescribed ORAL AND IV bisphosphonates (BP)
Boniva (inandronate)
how does Denosumab (Prolia, Xgeva) work?
stops the osteoclasts
how does anti-angiogenic agents work?
stop the blood supply in certain areas
what can happen when anti-angiogenic agents stop the formation of new vessels?
affects healing of soft tissues and patient can et necrosis
why necrosis in the jaws?
- increased bone turnover in the jaws
2. thin overlying oral mucosa due to jaw anatomy
remodeling rate of jaw is how many times more than long bones?
10x
according to AAOMS position paper, how do you manage a patient about to begin IV therapy?
- delay therapy, if systemic conditions permit
- optimize oral health prior to initiating therapy
- allow adequate osseous healing and wait until the surgery sites become mucosalized
how long does it take for surgery sites to become mucosalized?
14-21 days
according to AAOMS position paper, how do you manage an asymptomatic patient receiving IV therapy?
- maintain oral hygiene
2. avoid osseous injury
T/F: according to AAOMS position paper, managing an asymptomatic patient taking oral bisphosphonates (BP) is still lacking sound recommendations
true
according to AAOMS position paper, how do you manage an asymptomatic patient taking oral bisphosphonates (BP) for <4 years?
proceed with planned tx
according to AAOMS position paper, how do you manage an asymptomatic patient taking oral bisphosphonates (BP) for <4 years and risk factor (steroid/anti-angiogenic meds)?
stop BP therapy 2 months prior to tx
according to AAOMS position paper, how do you manage an asymptomatic patient taking oral bisphosphonates (BP) >4 years?
drug holiday for 2 months